CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ±è½Â±â
  • ¿Ü°úºÎÀå
    À¯¹æ¾Ï¼¾ÅÍÀå
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : À¯¹æ/Á¾¾ç¿Ü°ú
  • Á÷ À§: ºÎ±³¼ö(¿Ü°úºÎÀå,À¯¹æ¾Ï¼¾ÅÍÀå)
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
55 (±¹¿Ü)SCIE Prognostic significance of vascular endothelial growth factor gene polymorphisms in patients with colorectal cancer
54 (±¹³»)SCOPUS Hyperbilirubinemia is a significant indicator for the severity of acute appendicitis
53 (±¹¿Ü)SCI Association of eNOS polymorphisms (-786T-C, 4a4b, 894G-T) with colorectal cancer susceptibility in the Korean population
52 (±¹³»)SCOPUS Cyclooxygenase and Prostaglandin in Cancer
51 (±¹¿Ü)SCI Development of a LC?MS method for quantification of FK-3000 and its application to in vivo pharmacokinetic study in drug development
50 (±¹¿Ü)SCI Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population.
49 (±¹¿Ü)SCI Insertion of a self-expanding metal stentfor a stomal stenosis
48 (±¹³»)SCIE Survey of the Application of the Korean Clinical Practice Recommendations on Breast Cancer Treatment: The Utility of the Korean Breast Cancer Society Guidelines
47 (±¹¿Ü)SCIE Prognostic significance of microRNA gene polymorphisms in patients with surgically resected colorectal cancer
46 (±¹¿Ü)SCI Association of the miR-146aC-G, 149C-T, 196a2C-T, and 499A-G Polymorphisms With Colorectal Cancer in the Korean Population
ÀÌÀüÆäÀÌÁö À̵¿ 11 12 13 14 15 16 17 18 19 20 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729